No products in the cart.
Lenalidomide may boost prognosis in diffuse large B-cell lymphoma
1. The addition of lenalidomide to standard R-CHOP chemotherapy reduced the negative prognostic impact of non-GCB phenotype in diffuse large ...
Tag: B-cell lymphoma
Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma
1. The MYD88 mutation was associated with a shorter survival rate in primary cutaneous diffuse large B-cell lymphoma, leg type ...
2 Minute Medicine Rewind: May 20 – May 27
May 20 - 27, 2013 In this section, we will highlight the some of the high-impact studies, updates, and analyses ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.